Kamada Ltd. (TLV:KMDA)
2,510.00
-5.00 (-0.20%)
Feb 5, 2026, 5:27 PM IDT
Kamada Market Cap
Kamada has a market cap or net worth of 1.45 billion as of February 5, 2026. Its market cap has decreased by -4.97% in one year.
Market Cap
1.45B
Enterprise Value
1.25B
Revenue
578.74M
Ranking
n/a
PE Ratio
21.68
Stock Price
2,510.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.45B, an increase of 1,616.41%. That is a compound annual growth rate of 14.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 1.45B | 11.06% |
| Dec 31, 2025 | 1.30B | 2.55% |
| Dec 31, 2024 | 1.27B | -0.69% |
| Dec 31, 2023 | 1.28B | 108.12% |
| Dec 29, 2022 | 615.02M | -33.18% |
| Dec 30, 2021 | 920.36M | -0.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 128.45B |
| Danel (Adir Yeoshua) | 2.82B |
| BrainsWay | 1.41B |
| SofWave Medical | 1.30B |
| Bait Bakfar | 1.01B |
| Ilex Medical | 723.53M |
| Novolog (Pharm-Up 1966) | 607.94M |
| Bonus BioGroup | 532.57M |